Review
Version 1
Preserved in Portico This version is not peer-reviewed
Pregnant Women: A Global Perspective of the Scientific Literature
Version 1
: Received: 14 June 2024 / Approved: 14 June 2024 / Online: 17 June 2024 (08:34:08 CEST)
How to cite: Lima, G. G.; De Gaspari, E. Pregnant Women: A Global Perspective of the Scientific Literature. Preprints 2024, 2024061095. https://doi.org/10.20944/preprints202406.1095.v1 Lima, G. G.; De Gaspari, E. Pregnant Women: A Global Perspective of the Scientific Literature. Preprints 2024, 2024061095. https://doi.org/10.20944/preprints202406.1095.v1
Abstract
For the World Health Organization, and specifically for the International Coordination Committee, the need to bring forward discussions on non-clinical trials in human models, such as vaccine trials in pregnant women, with the aim of demonstrating immunity in newborns, has been addressed. This literature review seeks to investigate the relationship between mothers and newborns in terms of the transfer of IgG antibodies against SARS-CoV-2. Most of the literary evidence shows that the substantial transfer of transplacental and lactational antibodies to infants confers protection even when the baby is exposed to the disease. However, accurate and conclusive evidence on the safety and efficacy of COVID-19 vaccines during pregnancy will be a key factor in facilitating the decision-making process for pregnant women to ensure the safety of mother and baby.
Keywords
Pregnancy; SARS-CoV-2; Immunization
Subject
Biology and Life Sciences, Immunology and Microbiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
